MENU
BBIO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BridgeBio Pharma (BBIO) Ownership - Who owns BridgeBio Pharma?
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases... Show more
Profile
Industry
N/A
Address
3160 Porter Drive
Phone
+1 650 391-9740
Employees
556
Web
https://www.bridgebio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
6.4B
P/E Ratio
N/A
Total Cash
540.6M
Projected Growth
N/A
Total Debt
1.86B
Revenue
127.42M
Risk (Beta)
0.97
Dividend Yield
N/A
Total Cash/Share
2.85
Total Debt/Equity
N/A
Revenue/Share
0.67 USD as % of share price
Fundamentals
BBIO
Capitalization
6.4B
P/E Ratio
N/A
Risk (Beta)
0.97
Dividend Yield
N/A
Total Cash
541M
Total Cash/Share
2.85
Total Debt
1.86B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.67%
Revenue
127M
ROE
N/A
Book Value
-1.65B
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-3.56
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
197K
Current Ratio
4.57
Current Revenue Per Employee
159771.23
Dividends Per Share - Security
N/A
EBITDA
-551.92M
Float
N/A
Float - Current
N/A
Gross Income Margin
97.74
Revenue To Assets
-77.18
Shares Held By Institutions
9.7B
Shares Outstanding - Current
190M
Total Liabilities
2.52B
Total Volume MTD
N/A
Value
1
Gain YTD
19.679
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company which engages in developing transformative medicines to treat patients who suffer from mendelian diseases.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
3160 Porter Drive
Phone
+1 650 391-9740
Employees
556
Web
https://www.bridgebio.com